ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(M351T)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.8
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(F317L)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.7
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(H396P)-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
10.6
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
10.5
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(F317L)-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
10.5
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(Q252H)-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
10.4
|
pKd
|
0.0
|
Kd
|
EPH receptor B6
|
EPHB6 |
Hs |
Inhibitor |
Inhibition |
10.4
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(F317I)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.4
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(H396P)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.3
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.3
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(E255K)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.3
|
pKd
|
0.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(Y253F)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.2
|
pKd
|
0.1
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(Q252H)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
10.2
|
pKd
|
0.1
|
Kd
|
EPH receptor A3
|
EPHA3 |
Hs |
Inhibitor |
Inhibition |
10.0
|
pKd
|
0.1
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(F317I)-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
10.0
|
pKd
|
0.1
|
Kd
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
ABL2 |
Hs |
Inhibitor |
Inhibition |
9.8
|
pKd
|
0.2
|
Kd
|
LCK proto-oncogene, Src family tyrosine kinase
|
LCK |
Hs |
Inhibitor |
Inhibition |
9.7
|
pKd
|
0.2
|
Kd
|
BLK proto-oncogene, Src family tyrosine kinase
|
BLK |
Hs |
Inhibitor |
Inhibition |
9.7
|
pKd
|
0.2
|
Kd
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
SRC |
Hs |
Inhibitor |
Inhibition |
9.7
|
pKd
|
0.2
|
Kd
|
EPH receptor A5
|
EPHA5 |
Hs |
Inhibitor |
Inhibition |
9.6
|
pKd
|
0.2
|
Kd
|
EPH receptor A8
|
EPHA8 |
Hs |
Inhibitor |
Inhibition |
9.6
|
pKd
|
0.2
|
Kd
|
YES proto-oncogene 1, Src family tyrosine kinase
|
YES |
Hs |
Inhibitor |
Inhibition |
9.5
|
pKd
|
0.3
|
Kd
|
fyn related Src family tyrosine kinase
|
FRK |
Hs |
Inhibitor |
Inhibition |
9.5
|
pKd
|
0.3
|
Kd
|
EPH receptor B4
|
EPHB4 |
Hs |
Inhibitor |
Inhibition |
9.5
|
pKd
|
0.3
|
Kd
|
HCK proto-oncogene, Src family tyrosine kinase
|
HCK |
Hs |
Inhibitor |
Inhibition |
9.5
|
pKd
|
0.3
|
Kd
|
EPH receptor B2
|
EPHB2 |
Hs |
Inhibitor |
Inhibition |
9.4
|
pKd
|
0.4
|
Kd
|
EPH receptor B1
|
EPHB1 |
Hs |
Inhibitor |
Inhibition |
9.4
|
pKd
|
0.4
|
Kd
|
platelet derived growth factor receptor alpha
|
PDGFRA |
Hs |
Inhibitor |
Inhibition |
9.3
|
pKd
|
0.5
|
Kd
|
FGR proto-oncogene, Src family tyrosine kinase
|
FGR |
Hs |
Inhibitor |
Inhibition |
9.3
|
pKd
|
0.5
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(L576P) |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.6
|
Kd
|
LYN proto-oncogene, Src family tyrosine kinase
|
LYN |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.6
|
Kd
|
colony stimulating factor 1 receptor
|
CSF1R |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.6
|
Kd
|
platelet derived growth factor receptor beta
|
PDGFRB |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.6
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(A829P) |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.7
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(V559D) |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.7
|
Kd
|
discoidin domain receptor tyrosine kinase 1
|
DDR1 |
Hs |
Inhibitor |
Inhibition |
9.2
|
pKd
|
0.7
|
Kd
|
FYN proto-oncogene, Src family tyrosine kinase
|
FYN |
Hs |
Inhibitor |
Inhibition |
9.1
|
pKd
|
0.8
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT |
Hs |
Inhibitor |
Inhibition |
9.1
|
pKd
|
0.8
|
Kd
|
EPH receptor A2
|
EPHA2 |
Hs |
Inhibitor |
Inhibition |
9.1
|
pKd
|
0.9
|
Kd
|
colony stimulating factor 1 receptor
|
CSF1R-autoinhibited |
Hs |
Inhibitor |
Inhibition |
9.0
|
pKd
|
1.0
|
Kd
|
C-terminal Src kinase
|
CSK |
Hs |
Inhibitor |
Inhibition |
9.0
|
pKd
|
1.0
|
Kd
|
EPH receptor A4
|
EPHA4 |
Hs |
Inhibitor |
Inhibition |
8.9
|
pKd
|
1.2
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT-autoinhibited |
Hs |
Inhibitor |
Inhibition |
8.9
|
pKd
|
1.2
|
Kd
|
BMX non-receptor tyrosine kinase
|
BMX |
Hs |
Inhibitor |
Inhibition |
8.9
|
pKd
|
1.4
|
Kd
|
Bruton tyrosine kinase
|
BTK |
Hs |
Inhibitor |
Inhibition |
8.9
|
pKd
|
1.4
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(D816H) |
Hs |
Inhibitor |
Inhibition |
8.8
|
pKd
|
1.6
|
Kd
|
TXK tyrosine kinase
|
TXK |
Hs |
Inhibitor |
Inhibition |
8.7
|
pKd
|
2.1
|
Kd
|
cyclin G associated kinase
|
GAK |
Hs |
Inhibitor |
Inhibition |
8.6
|
pKd
|
2.6
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(D816V) |
Hs |
Inhibitor |
Inhibition |
8.6
|
pKd
|
2.6
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(V559D,V654A) |
Hs |
Inhibitor |
Inhibition |
8.6
|
pKd
|
2.7
|
Kd
|
discoidin domain receptor tyrosine kinase 2
|
DDR2 |
Hs |
Inhibitor |
Inhibition |
8.5
|
pKd
|
3.2
|
Kd
|
mitogen-activated protein kinase kinase 5
|
MEK5 |
Hs |
Inhibitor |
Inhibition |
8.5
|
pKd
|
3.3
|
Kd
|
salt inducible kinase 1
|
SIK |
Hs |
Inhibitor |
Inhibition |
8.4
|
pKd
|
3.9
|
Kd
|
EPH receptor A1
|
EPHA1 |
Hs |
Inhibitor |
Inhibition |
8.4
|
pKd
|
4.1
|
Kd
|
tyrosine kinase non receptor 2
|
TNK2 |
Hs |
Inhibitor |
Inhibition |
8.3
|
pKd
|
5.6
|
Kd
|
salt inducible kinase 2
|
SIK2 |
Hs |
Inhibitor |
Inhibition |
8.2
|
pKd
|
6.4
|
Kd
|
EPH receptor B3
|
EPHB3 |
Hs |
Inhibitor |
Inhibition |
8.2
|
pKd
|
6.9
|
Kd
|
protein tyrosine kinase 6
|
BRK |
Hs |
Inhibitor |
Inhibition |
8.1
|
pKd
|
7.8
|
Kd
|
TNNI3 interacting kinase
|
TNNI3K |
Hs |
Inhibitor |
Inhibition |
8.0
|
pKd
|
11.0
|
Kd
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
|
SRMS |
Hs |
Inhibitor |
Inhibition |
7.9
|
pKd
|
13.0
|
Kd
|
tec protein tyrosine kinase
|
TEC |
Hs |
Inhibitor |
Inhibition |
7.9
|
pKd
|
13.0
|
Kd
|
erb-b2 receptor tyrosine kinase 3
|
ERBB3 |
Hs |
Inhibitor |
Inhibition |
7.7
|
pKd
|
18.0
|
Kd
|
mitogen-activated protein kinase 14
|
p38-alpha |
Hs |
Inhibitor |
Inhibition |
7.6
|
pKd
|
27.0
|
Kd
|
SIK family kinase 3
|
QSK |
Hs |
Inhibitor |
Inhibition |
7.6
|
pKd
|
28.0
|
Kd
|
receptor interacting serine/threonine kinase 2
|
RIPK2 |
Hs |
Inhibitor |
Inhibition |
7.5
|
pKd
|
31.0
|
Kd
|
testis associated actin remodelling kinase 1
|
TESK1 |
Hs |
Inhibitor |
Inhibition |
7.5
|
pKd
|
33.0
|
Kd
|
mitogen-activated protein kinase kinase kinase kinase 5
|
MAP4K5 |
Hs |
Inhibitor |
Inhibition |
7.3
|
pKd
|
45.0
|
Kd
|
ZAK sterile alpha motif and leucine zipper containing kinase AZK
|
ZAK |
Hs |
Inhibitor |
Inhibition |
7.3
|
pKd
|
45.0
|
Kd
|
bone morphogenetic protein receptor type IB
|
BMPR1B |
Hs |
Inhibitor |
Inhibition |
7.3
|
pKd
|
53.0
|
Kd
|
erb-b2 receptor tyrosine kinase 4
|
ERBB4 |
Hs |
Inhibitor |
Inhibition |
7.3
|
pKd
|
55.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(G719S) |
Hs |
Inhibitor |
Inhibition |
7.1
|
pKd
|
79.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 19
|
YSK4 |
Hs |
Inhibitor |
Inhibition |
7.1
|
pKd
|
79.0
|
Kd
|
LIM domain kinase 2
|
LIMK2 |
Hs |
Inhibitor |
Inhibition |
7.1
|
pKd
|
86.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L747-E749del, A750P) |
Hs |
Inhibitor |
Inhibition |
7.0
|
pKd
|
110.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L861Q) |
Hs |
Inhibitor |
Inhibition |
7.0
|
pKd
|
110.0
|
Kd
|
tyrosine kinase 2
|
TYK2(JH2domain-pseudokinase) |
Hs |
Inhibitor |
Inhibition |
7.0
|
pKd
|
110.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(T315I)-phosphorylated |
Hs |
Inhibitor |
Inhibition |
6.9
|
pKd
|
120.0
|
Kd
|
epidermal growth factor receptor
|
EGFR |
Hs |
Inhibitor |
Inhibition |
6.9
|
pKd
|
120.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L858R) |
Hs |
Inhibitor |
Inhibition |
6.9
|
pKd
|
120.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(E746-A750del) |
Hs |
Inhibitor |
Inhibition |
6.9
|
pKd
|
130.0
|
Kd
|
protein kinase, membrane associated tyrosine/threonine 1
|
PKMYT1 |
Hs |
Inhibitor |
Inhibition |
6.9
|
pKd
|
130.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 2
|
MAP3K2 |
Hs |
Inhibitor |
Inhibition |
6.8
|
pKd
|
140.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L747-T751del,Sins) |
Hs |
Inhibitor |
Inhibition |
6.8
|
pKd
|
160.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(G719C) |
Hs |
Inhibitor |
Inhibition |
6.8
|
pKd
|
170.0
|
Kd
|
coenzyme Q8A
|
ADCK3 |
Hs |
Inhibitor |
Inhibition |
6.7
|
pKd
|
190.0
|
Kd
|
WEE2 oocyte meiosis inhibiting kinase
|
WEE2 |
Hs |
Inhibitor |
Inhibition |
6.7
|
pKd
|
200.0
|
Kd
|
activin A receptor type 2A
|
ACVR2A |
Hs |
Inhibitor |
Inhibition |
6.7
|
pKd
|
210.0
|
Kd
|
serine/threonine kinase 36
|
STK36 |
Hs |
Inhibitor |
Inhibition |
6.7
|
pKd
|
210.0
|
Kd
|
transforming growth factor beta receptor 1
|
TGFBR1 |
Hs |
Inhibitor |
Inhibition |
6.6
|
pKd
|
230.0
|
Kd
|
nemo like kinase
|
NLK |
Hs |
Inhibitor |
Inhibition |
6.6
|
pKd
|
260.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 3
|
MAP3K3 |
Hs |
Inhibitor |
Inhibition |
6.6
|
pKd
|
280.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 4
|
MAP3K4 |
Hs |
Inhibitor |
Inhibition |
6.5
|
pKd
|
310.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L747-S752del, P753S) |
Hs |
Inhibitor |
Inhibition |
6.5
|
pKd
|
320.0
|
Kd
|
activin A receptor type 1B
|
ACVR1B |
Hs |
Inhibitor |
Inhibition |
6.5
|
pKd
|
330.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(S752-I759del) |
Hs |
Inhibitor |
Inhibition |
6.5
|
pKd
|
330.0
|
Kd
|
ret proto-oncogene
|
RET(M918T) |
Hs |
Inhibitor |
Inhibition |
6.4
|
pKd
|
390.0
|
Kd
|
mitogen-activated protein kinase 11
|
p38-beta |
Hs |
Inhibitor |
Inhibition |
6.4
|
pKd
|
410.0
|
Kd
|
misshapen like kinase 1
|
MINK |
Hs |
Inhibitor |
Inhibition |
6.4
|
pKd
|
430.0
|
Kd
|
activin A receptor type IL
|
ACVRL1 |
Hs |
Inhibitor |
Inhibition |
6.3
|
pKd
|
460.0
|
Kd
|
NIMA related kinase 11
|
NEK11 |
Hs |
Inhibitor |
Inhibition |
6.3
|
pKd
|
470.0
|
Kd
|
B-Raf proto-oncogene, serine/threonine kinase
|
BRAF |
Hs |
Inhibitor |
Inhibition |
6.3
|
pKd
|
500.0
|
Kd
|
activin A receptor type 2B
|
ACVR2B |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
570.0
|
Kd
|
B-Raf proto-oncogene, serine/threonine kinase
|
BRAF(V600E) |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
570.0
|
Kd
|
LIM domain kinase 1
|
LIMK1 |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
570.0
|
Kd
|
Raf-1 proto-oncogene, serine/threonine kinase
|
RAF1 |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
570.0
|
Kd
|
activin A receptor type 1
|
ACVR1 |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
620.0
|
Kd
|
Janus kinase 3
|
JAK3(JH1domain-catalytic) |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
640.0
|
Kd
|
mitogen-activated protein kinase kinase kinase kinase 3
|
MAP4K3 |
Hs |
Inhibitor |
Inhibition |
6.2
|
pKd
|
640.0
|
Kd
|
STE20 like kinase
|
SLK |
Hs |
Inhibitor |
Inhibition |
6.1
|
pKd
|
720.0
|
Kd
|
ret proto-oncogene
|
RET |
Hs |
Inhibitor |
Inhibition |
6.1
|
pKd
|
730.0
|
Kd
|
serine/threonine kinase 35
|
STK35 |
Hs |
Inhibitor |
Inhibition |
6.1
|
pKd
|
770.0
|
Kd
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
ABL1(T315I)-nonphosphorylated |
Hs |
Inhibitor |
Inhibition |
6.1
|
pKd
|
890.0
|
Kd
|
mitogen-activated protein kinase kinase kinase kinase 1
|
HPK1 |
Hs |
Inhibitor |
Inhibition |
6.0
|
pKd
|
980.0
|
Kd
|
Janus kinase 2
|
JAK2(JH1domain-catalytic) |
Hs |
Inhibitor |
Inhibition |
6.0
|
pKd
|
1000.0
|
Kd
|
mitogen-activated protein kinase kinase 1
|
MEK1 |
Hs |
Inhibitor |
Inhibition |
6.0
|
pKd
|
1000.0
|
Kd
|
CDC42 binding protein kinase gamma
|
DMPK2 |
Hs |
Inhibitor |
Inhibition |
5.9
|
pKd
|
1200.0
|
Kd
|
serine/threonine kinase 10
|
LOK |
Hs |
Inhibitor |
Inhibition |
5.9
|
pKd
|
1200.0
|
Kd
|
SH3 domain binding kinase 1
|
SBK1 |
Hs |
Inhibitor |
Inhibition |
5.9
|
pKd
|
1200.0
|
Kd
|
DM1 protein kinase
|
DMPK |
Hs |
Inhibitor |
Inhibition |
5.9
|
pKd
|
1300.0
|
Kd
|
mitogen-activated protein kinase kinase kinase kinase 2
|
MAP4K2 |
Hs |
Inhibitor |
Inhibition |
5.9
|
pKd
|
1300.0
|
Kd
|
erb-b2 receptor tyrosine kinase 2
|
ERBB2 |
Hs |
Inhibitor |
Inhibition |
5.8
|
pKd
|
1400.0
|
Kd
|
fibroblast growth factor receptor 2
|
FGFR2 |
Hs |
Inhibitor |
Inhibition |
5.8
|
pKd
|
1400.0
|
Kd
|
mitogen-activated protein kinase kinase 2
|
MEK2 |
Hs |
Inhibitor |
Inhibition |
5.8
|
pKd
|
1400.0
|
Kd
|
casein kinase 1 epsilon
|
CSNK1E |
Hs |
Inhibitor |
Inhibition |
5.8
|
pKd
|
1500.0
|
Kd
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
GCN2(Kin.Dom.2,S808G) |
Hs |
Inhibitor |
Inhibition |
5.8
|
pKd
|
1600.0
|
Kd
|
tyrosine kinase 2
|
TYK2(JH1domain-catalytic) |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
1800.0
|
Kd
|
serine/threonine-protein kinase MST4
|
MST4 |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
1900.0
|
Kd
|
CDC42 binding protein kinase alpha
|
MRCKA |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
2000.0
|
Kd
|
TRAF2 and NCK interacting kinase
|
TNIK |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
2000.0
|
Kd
|
EPH receptor A6
|
EPHA6 |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
2100.0
|
Kd
|
CDC42 binding protein kinase beta
|
MRCKB |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
2100.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(L858R,T790M) |
Hs |
Inhibitor |
Inhibition |
5.7
|
pKd
|
2200.0
|
Kd
|
epidermal growth factor receptor
|
EGFR(T790M) |
Hs |
Inhibitor |
Inhibition |
5.6
|
pKd
|
2300.0
|
Kd
|
TAO kinase 3
|
TAOK3 |
Hs |
Inhibitor |
Inhibition |
5.6
|
pKd
|
2300.0
|
Kd
|
spleen associated tyrosine kinase
|
SYK |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
2900.0
|
Kd
|
transforming growth factor beta receptor 2
|
TGFBR2 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
2900.0
|
Kd
|
kinase insert domain receptor
|
VEGFR2 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
2900.0
|
Kd
|
AP2 associated kinase 1
|
AAK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
coenzyme Q8B
|
ADCK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
AKT serine/threonine kinase 1
|
AKT1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
AKT serine/threonine kinase 2
|
AKT2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
AKT serine/threonine kinase 3
|
AKT3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ALK receptor tyrosine kinase
|
ALK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase AMP-activated catalytic subunit alpha 1
|
AMPK-alpha1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase AMP-activated catalytic subunit alpha 2
|
AMPK-alpha2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ankyrin repeat and kinase domain containing 1
|
ANKK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NUAK family kinase 1
|
ARK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 5
|
ASK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 6
|
ASK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
aurora kinase B
|
AURKB |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
aurora kinase C
|
AURKC |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
AXL receptor tyrosine kinase
|
AXL |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
BMP2 inducible kinase
|
BIKE |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
bone morphogenetic protein receptor type 2
|
BMPR2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
BR serine/threonine kinase 1
|
BRSK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
BR serine/threonine kinase 2
|
BRSK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase I
|
CAMK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase ID
|
CAMK1D |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase IG
|
CAMK1G |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin-dependent protein kinase II alpha subunit
|
CAMK2A |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin-dependent protein kinase II beta subunit
|
CAMK2B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin-dependent protein kinase II delta subunit
|
CAMK2D |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin-dependent protein kinase II gamma subunit
|
CAMK2G |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase IV
|
CAMK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase kinase 1
|
CAMKK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent protein kinase kinase 2
|
CAMKK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
calcium/calmodulin dependent serine protein kinase
|
CASK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 11B
|
CDC2L1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 11A
|
CDC2L2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 13
|
CDC2L5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 19
|
CDK11 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 2
|
CDK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 3
|
CDK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 4
|
CDK4-cyclinD1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 4
|
CDK4-cyclinD3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 5
|
CDK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 7
|
CDK7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 8
|
CDK8 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 9
|
CDK9 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase like 1
|
CDKL1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase like 2
|
CDKL2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin-dependent kinase like 3
|
CDKL3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin-dependent kinase like 4
|
CDKL5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
checkpoint kinase 1
|
CHEK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
checkpoint kinase 2
|
CHEK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
citron rho-interacting serine/threonine kinase
|
CIT |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
CDC like kinase 1
|
CLK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
CDC like kinase 2
|
CLK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
CDC like kinase 3
|
CLK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
CDC like kinase 4
|
CLK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 alpha 1
|
CSNK1A1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 alpha 1 like
|
CSNK1A1L |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 delta
|
CSNK1D |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 gamma 1
|
CSNK1G1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 gamma 2
|
CSNK1G2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 1 gamma 3
|
CSNK1G3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 2, alpha 1 polypeptide subunit
|
CSNK2A1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
casein kinase 2, alpha prime polypeptide subunit
|
CSNK2A2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
megakaryocyte-associated tyrosine kinase
|
CTK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
death associated protein kinase 1
|
DAPK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
death associated protein kinase 2
|
DAPK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
death associated protein kinase 3
|
DAPK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
doublecortin like kinase 1
|
DCAMKL1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
doublecortin like kinase 2
|
DCAMKL2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
doublecortin like kinase 3
|
DCAMKL3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 12
|
DLK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 17a
|
DRAK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 17b
|
DRAK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
DYRK1A |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
dual specificity tyrosine phosphorylation regulated kinase 1B
|
DYRK1B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
dual specificity tyrosine phosphorylation regulated kinase 2
|
DYRK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
eukaryotic translation initiation factor 2 alpha kinase 1
|
EIF2AK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
EPH receptor A7
|
EPHA7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 3
|
ERK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 1
|
ERK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 6
|
ERK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 4
|
ERK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 7
|
ERK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 15
|
ERK8 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
endoplasmic reticulum to nucleus signaling 1
|
ERN1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein tyrosine kinase 2
|
FAK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
FER tyrosine kinase
|
FER |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
FES proto-oncogene, tyrosine kinase
|
FES |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
fibroblast growth factor receptor 3
|
FGFR3(G697C) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
fibroblast growth factor receptor 4
|
FGFR4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(R834Q) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
fms related receptor tyrosine kinase 4
|
FLT4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
G protein-coupled receptor kinase 1
|
GRK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
G protein-coupled receptor kinase 4
|
GRK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
G protein-coupled receptor kinase 7
|
GRK7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
glycogen synthase kinase 3 alpha
|
GSK3A |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
glycogen synthase kinase 3 beta
|
GSK3B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
homeodomain interacting protein kinase 1
|
HIPK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
homeodomain interacting protein kinase 2
|
HIPK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
homeodomain interacting protein kinase 3
|
HIPK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
homeodomain interacting protein kinase 4
|
HIPK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
hormonally up-regulated Neu-associated kinase
|
HUNK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ciliogenesis associated kinase 1
|
ICK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Insulin-like growth factor I receptor
|
IGF1R |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
component of inhibitor of nuclear factor kappa B kinase complex
|
IKK-alpha |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
IKK-beta |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
IKK-epsilon |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Insulin receptor
|
INSR |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Insulin receptor-related receptor
|
INSRR |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
interleukin 1 receptor associated kinase 1
|
IRAK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
interleukin 1 receptor associated kinase 3
|
IRAK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
interleukin 1 receptor associated kinase 4
|
IRAK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
IL2 inducible T cell kinase
|
ITK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Janus kinase 1
|
JAK1(JH1domain-catalytic) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Janus kinase 1
|
JAK1(JH2domain-pseudokinase) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 8
|
JNK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 9
|
JNK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 10
|
JNK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
KIT proto-oncogene, receptor tyrosine kinase
|
KIT(V559D,T670I) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
large tumor suppressor kinase 1
|
LATS1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
large tumor suppressor kinase 2
|
LATS2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 11
|
LKB1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
leucine rich repeat kinase 2
|
LRRK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
leucine rich repeat kinase 2
|
LRRK2(G2019S) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
leukocyte receptor tyrosine kinase
|
LTK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
male germ cell associated kinase
|
MAK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 1
|
MAP3K1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 15
|
MAP3K15 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MAPK activated protein kinase 2
|
MAPKAPK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MAPK activated protein kinase 5
|
MAPKAPK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
microtubule affinity regulating kinase 1
|
MARK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
microtubule affinity regulating kinase 2
|
MARK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
microtubule affinity regulating kinase 3
|
MARK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
microtubule affinity regulating kinase 4
|
MARK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Microtubule associated serine/threonine kinase 1
|
MAST1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase 3
|
MEK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase 4
|
MEK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase 6
|
MEK6 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
maternal embryonic leucine zipper kinase
|
MELK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MER proto-oncogene, tyrosine kinase
|
MERTK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MET proto-oncogene, receptor tyrosine kinase
|
MET |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MET proto-oncogene, receptor tyrosine kinase
|
MET(M1250T) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MET proto-oncogene, receptor tyrosine kinase
|
MET(Y1235D) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase 7
|
MKK7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MAPK interacting serine/threonine kinase 1
|
MKNK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
MAPK interacting serine/threonine kinase 2
|
MKNK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
myosin light chain kinase 3
|
MLCK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 9
|
MLK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 10
|
MLK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 11
|
MLK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
macrophage stimulating 1 receptor
|
MST1R |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 3
|
MST2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 24
|
MST3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mechanistic target of rapamycin kinase
|
MTOR |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
muscle associated receptor tyrosine kinase
|
MUSK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
myosin light chain kinase
|
MYLK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
myosin light chain kinase family member 4
|
MYLK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
myosin IIIA
|
MYO3A |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
myosin IIIB
|
MYO3B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Serine/threonine kinase 38
|
NDR1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Serine/threonine kinase 38 like
|
NDR2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 1
|
NEK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 3
|
NEK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 4
|
NEK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 5
|
NEK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 6
|
NEK6 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 7
|
NEK7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NIMA related kinase 8
|
NEK9 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine-protein kinase NIM1
|
NIM1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
oxidative stress responsive kinase 1
|
OSR1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 13
|
p38-delta |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase 12
|
p38-gamma |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 1
|
PAK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 2
|
PAK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 3
|
PAK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 4
|
PAK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 6
|
PAK6 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
p21 (RAC1) activated kinase 5
|
PAK7 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 16
|
PCTK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 17
|
PCTK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 18
|
PCTK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
3-phosphoinositide dependent protein kinase 1
|
PDPK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 15
|
PFTAIRE2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
cyclin dependent kinase 14
|
PFTK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphorylase kinase catalytic subunit gamma 1
|
PHKG1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphorylase kinase catalytic subunit gamma 2
|
PHKG2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta
|
PIK3C2B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
|
PIK3C2G |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(C420R) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(E542K) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(E545A) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(E545K) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(H1047L) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(H1047Y) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(I800L) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(M1043I) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
PIK3CA(Q546K) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
PIK3CB |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
PIK3CD |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
PIK3CG |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol 4-kinase alpha
|
PIK4CB |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Pim-1 proto-oncogene, serine/threonine kinase
|
PIM1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Pim-2 proto-oncogene, serine/threonine kinase
|
PIM2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Pim-3 proto-oncogene, serine/threonine kinase
|
PIM3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4-phosphate 5-kinase type 1 alpha
|
PIP5K1A |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma
|
PIP5K1C |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
|
PIP5K2B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
|
PIP5K2C |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase, cAMP-dependent, catalytic, alpha subunit
|
PKAC-alpha |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase, cAMP-dependent, catalytic, beta subunit
|
PKAC-beta |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase N1
|
PKN1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase N2
|
PKN2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
polo like kinase 1
|
PLK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
polo like kinase 2
|
PLK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
polo like kinase 3
|
PLK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
polo like kinase 4
|
PLK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase C delta
|
PRKCD |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase C epsilon
|
PRKCE |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase C eta
|
PRKCH |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase C iota
|
PRKCI |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase C theta
|
PRKCQ |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase D1
|
PRKD1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase D2
|
PRKD2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase D3
|
PRKD3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Protein kinase G (PKG) 1
|
PRKG1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Protein kinase G (PKG) 2
|
PRKG2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
eukaryotic translation initiation factor 2 alpha kinase 2
|
PRKR |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein kinase X-linked
|
PRKX |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
pre-mRNA processing factor kinase PRP4K
|
PRP4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
protein tyrosine kinase 2 beta
|
PYK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ret proto-oncogene
|
RET(V804M) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
RIO kinase 1
|
RIOK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
RIO kinase 2
|
RIOK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
RIO kinase 3
|
RIOK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
receptor interacting serine/threonine kinase 1
|
RIPK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
receptor interacting serine/threonine kinase 4
|
RIPK4 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
dual serine/threonine and tyrosine protein kinase
|
RIPK5 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Rho associated coiled-coil containing protein kinase 1
|
ROCK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
Rho associated coiled-coil containing protein kinase 2
|
ROCK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
c-ros oncogene 1, receptor tyrosine kinase
|
ROS1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A4
|
RPS6KA4(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A4
|
RPS6KA4(Kin.Dom.2-C-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A5
|
RPS6KA5(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A5
|
RPS6KA5(Kin.Dom.2-C-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A1
|
RSK1(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A1
|
RSK1(Kin.Dom.2-C-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A3
|
RSK2(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A2
|
RSK3(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A2
|
RSK3(Kin.Dom.2-C-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A6
|
RSK4(Kin.Dom.1-N-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase A6
|
RSK4(Kin.Dom.2-C-terminal) |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
ribosomal protein S6 kinase B1
|
S6K1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
sugen kinase 110
|
SgK110 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serum/glucocorticoid regulated kinase family member 3
|
SGK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
NUAK family, SNF1-like kinase, 2
|
SNARK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
SNF related kinase
|
SNRK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
SRSF protein kinase 1
|
SRPK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
SRSF protein kinase 2
|
SRPK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
SRSF protein kinase 3
|
SRPK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 16
|
STK16 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 33
|
STK33 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 39
|
STK39 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TAO kinase 1
|
TAOK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TANK binding kinase 1
|
TBK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
tyrosine kinase with immunoglobulin like and EGF like domains 1
|
TIE1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TEK receptor tyrosine kinase
|
TIE2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
tousled like kinase 1
|
TLK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
tousled like kinase 2
|
TLK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
tyrosine kinase non receptor 1
|
TNK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
neurotrophic receptor tyrosine kinase 1
|
TRKA |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
neurotrophic receptor tyrosine kinase 2
|
TRKB |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
neurotrophic receptor tyrosine kinase 3
|
TRKC |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TRPM6
|
TRPM6 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
testis specific serine kinase 1B
|
TSSK1B |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TTK protein kinase
|
TTK |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
TYRO3 protein tyrosine kinase
|
TYRO3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
unc-51 like autophagy activating kinase 1
|
ULK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
unc-51 like autophagy activating kinase 2
|
ULK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 32A
|
YANK1 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 32B
|
YANK2 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
serine/threonine kinase 32C
|
YANK3 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
zeta chain of T cell receptor associated protein kinase 70
|
ZAP70 |
Hs |
Inhibitor |
Inhibition |
<5.5
|
pKd
|
>3000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase kinase 4
|
MAP4K4 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3100.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(K663Q) |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3200.0
|
Kd
|
ret proto-oncogene
|
RET(V804L) |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3200.0
|
Kd
|
VRK serine/threonine kinase 2
|
VRK2 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3200.0
|
Kd
|
serine/threonine kinase 25
|
YSK1 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3400.0
|
Kd
|
myosin light chain kinase 2
|
MYLK2 |
Hs |
Inhibitor |
Inhibition |
5.5
|
pKd
|
3500.0
|
Kd
|
fibroblast growth factor receptor 1
|
FGFR1 |
Hs |
Inhibitor |
Inhibition |
5.4
|
pKd
|
3700.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 7
|
TAK1 |
Hs |
Inhibitor |
Inhibition |
5.4
|
pKd
|
3700.0
|
Kd
|
serine/threonine kinase 4
|
MST1 |
Hs |
Inhibitor |
Inhibition |
5.4
|
pKd
|
3800.0
|
Kd
|
fibroblast growth factor receptor 3
|
FGFR3 |
Hs |
Inhibitor |
Inhibition |
5.4
|
pKd
|
3900.0
|
Kd
|
unc-51 like kinase 3
|
ULK3 |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
4600.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3 |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
4800.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(D835Y) |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
4800.0
|
Kd
|
fms related receptor tyrosine kinase 1
|
FLT1 |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
5000.0
|
Kd
|
mitogen-activated protein kinase kinase kinase 13
|
LZK |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
5300.0
|
Kd
|
TAO kinase 2
|
TAOK2 |
Hs |
Inhibitor |
Inhibition |
5.3
|
pKd
|
5400.0
|
Kd
|
NIMA related kinase 2
|
NEK2 |
Hs |
Inhibitor |
Inhibition |
5.2
|
pKd
|
6500.0
|
Kd
|
bone morphogenetic protein receptor type IA
|
BMPR1A |
Hs |
Inhibitor |
Inhibition |
5.2
|
pKd
|
7000.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(N841I) |
Hs |
Inhibitor |
Inhibition |
5.2
|
pKd
|
7000.0
|
Kd
|
WEE1 G2 checkpoint kinase
|
WEE1 |
Hs |
Inhibitor |
Inhibition |
5.2
|
pKd
|
7000.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(D835H) |
Hs |
Inhibitor |
Inhibition |
5.1
|
pKd
|
8100.0
|
Kd
|
aurora kinase A
|
AURKA |
Hs |
Inhibitor |
Inhibition |
5.0
|
pKd
|
9300.0
|
Kd
|
fms related receptor tyrosine kinase 3
|
FLT3(ITD) |
Hs |
Inhibitor |
Inhibition |
5.0
|
pKd
|
9900.0
|
Kd
|